IRIDEX Corporation (IRIX) Stock Analysis
A live, multi-source view of IRIDEX Corporation (IRIX): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About IRIDEX Corporation
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders.
Sector: Healthcare · Industry: Medical Devices · United States · 93 employees · iridex.com
Key statistics · as of 2026-09-06
As of 2026-09-06, IRIDEX Corporation (IRIX) had a market capitalization of $12.2M and a beta of 0.63; the shares traded in a 52-week range of $0.69 – $1.65 (-49.3% over the year).
- Market cap
- $12.2M
- Enterprise value
- $17.6M
- PEG ratio
- 0.94
- EPS (trailing)
- $-0.20
- EPS (forward)
- $0.00
- Payout ratio
- 0.0%
- 52-week range
- $0.69 – $1.65
- 52-week change
- -49.3%
- Beta
- 0.63
- Average volume
- 66,290
- Shares outstanding
- 17.4M
- Short % of float
- 0.34%
- Profit margin
- -6.9%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-10
In RapidTradeView’s 2026-09-10 scan of the US universe, IRIDEX Corporation (IRIX) last closed at $0.68 (the last completed close before that scan).
Technicals at the scan: RSI 29 (oversold territory), price -10.5% versus its 20-day average, 20-day versus 50-day average spread -13.6%, MACD histogram 0.00.
Sentiment inputs: StockTwits 100% bullish.
Next scheduled company event: in 68 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of IRIX; corporate insiders filed 2 buys and 0 sells (1 filer, latest disclosure 2026-08-24). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Romeo R. Dizon (2B/0S). Who is trading what
RapidTradeView pick record
IRIX has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls IRIDEX Corporation (IRIX) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell IRIX.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.